Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-24-001285
Filing Date
2024-11-18
Accepted
2024-11-18 16:36:00
Documents
1
Group Members
AARON COWENAVERILL MADISON MASTER FUND, LTD.AVERILL MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #2 s8147572b.htm SC 13D/A 78030
  Complete submission text file 0000899140-24-001285.txt   79699
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

EIN.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Subject) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91726 | Film No.: 241471977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)